Skip Nav Destination
Issues
1 April 2015
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1055-9965
EISSN 1538-7755
Highlights
Review
CEBP Report
Survivors of Childhood Cancer in the United States: Prevalence and Burden of Morbidity
Siobhan M. Phillips; Lynne S. Padgett; Wendy M. Leisenring; Kayla K. Stratton; Ken Bishop; Kevin R. Krull; Catherine M. Alfano; Todd M. Gibson; Janet S. de Moor; Danielle Blanch Hartigan; Gregory T. Armstrong; Leslie L. Robison; Julia H. Rowland; Kevin C. Oeffinger; Angela B. Mariotto
Research Articles
Population Distribution of Lifetime Risk of Ovarian Cancer in the United States
Celeste Leigh Pearce; Daniel O. Stram; Roberta B. Ness; Douglas A. Stram; Lynda D. Roman; Claire Templeman; Alice W. Lee; Usha Menon; Peter A. Fasching; Jessica N. McAlpine; Jennifer A. Doherty; Francesmary Modugno; Joellen M. Schildkraut; Mary Anne Rossing; David G. Huntsman; Anna H. Wu; Andrew Berchuck; Malcolm C. Pike; Paul D.P. Pharoah
Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis
Krystle A. Lang Kuhs; Devasena Anantharaman; Tim Waterboer; Mattias Johansson; Paul Brennan; Angelika Michel; Martina Willhauck-Fleckenstein; Mark P. Purdue; Ivana Holcátová; Wolfgang Ahrens; Pagona Lagiou; Jerry Polesel; Lorenzo Simonato; Franco Merletti; Claire M. Healy; Kristina Kjaerheim; David I. Conway; Tatiana V. Macfarlane; Peter Thomson; Xavier Castellsagué; Ariana Znaor; Amanda Black; Wen-Yi Huang; Vittorio Krogh; Antonia Trichopoulou; H. B(as). Bueno-de-Mesquita; Françoise Clavel-Chapelon; Elisabete Weiderpass; Johanna Ekström; Elio Riboli; Anne Tjønneland; María-José Sánchez; Ruth C. Travis; Allan Hildesheim; Michael Pawlita; Aimée R. Kreimer
Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers
Julie Lecarpentier; on behalf of GENEPSO; Catherine Noguès; on behalf of GENEPSO; Emmanuelle Mouret-Fourme; on behalf of GENEPSO; Bruno Buecher; on behalf of GENEPSO; Marion Gauthier-Villars; on behalf of GENEPSO; Dominique Stoppa-Lyonnet; on behalf of GENEPSO; Valérie Bonadona; on behalf of GENEPSO; Jean-Pierre Fricker; on behalf of GENEPSO; Pascaline Berthet; on behalf of GENEPSO; Olivier Caron; on behalf of GENEPSO; Isabelle Coupier; on behalf of GENEPSO; Pascal Pujol; on behalf of GENEPSO; Laurence Faivre; on behalf of GENEPSO; Paul Gesta; on behalf of GENEPSO; François Eisinger; on behalf of GENEPSO; Véronique Mari; on behalf of GENEPSO; Laurence Gladieff; on behalf of GENEPSO; Alain Lortholary; on behalf of GENEPSO; Elisabeth Luporsi; on behalf of GENEPSO; Dominique Leroux; on behalf of GENEPSO; Laurence Venat-Bouvet; on behalf of GENEPSO; Christine M. Maugard; on behalf of GENEPSO; Chrystelle Colas; on behalf of GENEPSO; Julie Tinat; on behalf of GENEPSO; Christine Lasset; on behalf of GENEPSO; Nadine Andrieu; on behalf of GENEPSO
Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women
Lori S. Tillmans; Robert A. Vierkant; Alice H. Wang; Niloy Jewel Samadder; Charles F. Lynch; Kristin E. Anderson; Amy J. French; Robert W. Haile; Lisa J. Harnack; John D. Potter; Susan L. Slager; Thomas C. Smyrk; Stephen N. Thibodeau; James R. Cerhan; Paul J. Limburg
Accuracy of Self-Reported Nevus and Pigmentation Phenotype Compared with Clinical Assessment in a Population-Based Study of Young Australian Adults
Anne E. Cust; Kristen M. Pickles; Chris Goumas; Thao Vu; Helen Schmid; Eduardo Nagore; John Kelly; Joanne F. Aitken; Graham G. Giles; John L. Hopper; Mark A. Jenkins; Graham J. Mann
Null Results in Brief
ASPO 39th Annual Meeting Abstracts
Decision Making about Contralateral Prophylactic Mastectomy Among BRCA1/2 Noncarriers with Newly-diagnosed Breast Cancer: Examining Cognitive, Emotional, and Sociodemographic Influences
JG Hamilton; M Salerno; K Amoroso; M Sheehan; M Harlan Fleischut; E Glogowski; B Siegel; AG Arnold; EE Salo-Mullen; J Hay; K Offit; ME Robson
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.